|
Use Of Antihypertensive Drugs By Medicare Enrollees: Does Type Of Drug Coverage Matter?
Alyce S. Adams,
Stephen B. Soumerai and
Dennis Ross-Degnan
Research has demonstrated that Medicare beneficiaries with drug coverage consume more clinically essential drugs. However, generosity of coverage varies considerably across beneficiaries. This study examines the association between types of drug coverage and the consumption and cost per tablet of essential antihypertensive medications among beneficiaries with hypertension. The findings indicate that while both state- and employer-sponsored drug coverage are associated with greater consumption of antihypertensive drugs and lower out-of-pocket costs per tablet, private supplemental coverage is not associated with greater use and is associated with only slightly lower out-of-pocket costs than among noncovered beneficiaries.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
Z. Yang, D. B. Gilleskie, and E. C. Norton
Health Insurance, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics
J. Human Resources,
January 1, 2009;
44(1):
47 - 114.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. M. Madden, A. J. Graves, F. Zhang, A. S. Adams, B. A. Briesacher, D. Ross-Degnan, J. H. Gurwitz, M. Pierre-Jacques, D. G. Safran, G. S. Adler, et al.
Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D
JAMA,
April 23, 2008;
299(16):
1922 - 1928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Soumerai, M. Pierre-Jacques, F. Zhang, D. Ross-Degnan, A. S. Adams, J. Gurwitz, G. Adler, and D. G. Safran
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.
Arch Intern Med,
September 25, 2006;
166(17):
1829 - 1835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Rice and K. Y. Matsuoka
Book Review: The Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors
Med Care Res Rev,
December 1, 2004;
61(4):
415 - 452.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C.-W. Tseng, R. H. Brook, E. Keeler, W. N. Steers, and C. M. Mangione
Cost-Lowering Strategies Used by Medicare Beneficiaries Who Exceed Drug Benefit Caps and Have a Gap in Drug Coverage
JAMA,
August 25, 2004;
292(8):
952 - 960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-W. Tseng, R. H. Brook, E. Keeler, and C. M. Mangione
Impact of an Annual Dollar Limit or "Cap" on Prescription Drug Benefits for Medicare Patients
JAMA,
July 9, 2003;
290(2):
222 - 227.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Federman, A. S. Adams, D. Ross-Degnan, S. B. Soumerai, and J. Z. Ayanian
Supplemental Insurance and Use of Effective Cardiovascular Drugs Among Elderly Medicare Beneficiaries With Coronary Heart Disease
JAMA,
October 10, 2001;
286(14):
1732 - 1739.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
